Published in Nature on July 16, 1971
Interaction between amount and pattern of training in the induction of intermediate- and long-term memory for sensitization in aplysia. Learn Mem (2002) 1.40
Contextual modulation of memory consolidation. Learn Mem (2000) 1.09
The temporal dynamics of retention of a context memory: something is missing. Learn Mem (2005) 0.92
Susceptibility of memory consolidation during lapses in recall. Nat Commun (2013) 0.89
Interaction of inhibitory and facilitatory effects of conditioning trials on long-term memory formation. Learn Mem (2016) 0.75
Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett (2001) 2.86
Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med (1971) 2.07
Structural preferences of beta-galactoside-reactive lectins on Actinomyces viscosus T14V and Actinomyces naeslundii WVU45. Infect Immun (1983) 1.47
Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols. J Med Chem (1981) 1.34
Pulmonary hypertrophic osteoarthropathy, spider angiomata, and estrogen hyperexcretion in neoplasia. Ann Intern Med (1969) 1.13
Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas. Cancer Res (1982) 1.12
The cardiovascular acitivity of ICI 118,587 a novel beta-adrenoceptor partial agonist [proceedings]. Br J Pharmacol (1979) 1.09
Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol (1978) 1.07
Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma. Cancer (1980) 1.03
Estradiol production after ovariectomy for carcinoma of the breast. N Engl J Med (1969) 0.99
Preliminary trial of aminoglutethimide in breast cancer. Cancer (1973) 0.99
A novel series of potent and selective agonists at the opioid kappa-receptor. Eur J Pharmacol (1988) 0.97
Substrate specificity and other properties of alpha-L-fucosidase from human serum. J Biol Chem (1982) 0.95
Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens. Cancer (1973) 0.92
Squamous cell carcinoma arising in ovarian endometriosis. Gynecol Oncol (1978) 0.91
Tumor markers for ovarian cancer. Int Adv Surg Oncol (1979) 0.90
Adriamycin and bleomycin, alone and in combination, in gynecologic cancers. Cancer (1973) 0.90
Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. Am J Obstet Gynecol (1981) 0.89
Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study. Am J Obstet Gynecol (1983) 0.87
Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient. Cancer Res (1976) 0.87
Paraaortic lymph node evaluation in stage I endometrial carcinoma. Obstet Gynecol (1982) 0.86
Glycosyltransferase and glycosidase activities in ovarian cancer patients. Cancer Res (1979) 0.85
Estrogen secretion, biosynthesis and metabolism: their relationship to the menstrual cycle. Steroids (1966) 0.85
Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix. Gynecol Oncol (1984) 0.85
Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix. Am J Obstet Gynecol (1977) 0.85
In vivo observations on testosterone and estradiol-17 beta protein binding in women. J Clin Endocrinol Metab (1969) 0.85
High dose irradiation to biopsy confirmed aortic node metastases from carcinoma of the uterine cervix. Cancer (1977) 0.85
Elevated activity of cytidine 5'-monophospho-N-acetylneuraminic acid hydrolase in serum of ovarian cancer patients as a possible indicator of malignancy. Biochem Biophys Res Commun (1978) 0.82
Profile and possible origin of an adrenocortical carcinoma. J Clin Endocrinol Metab (1971) 0.81
Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary. Cancer Res (1974) 0.81
Para-aortic lymph node irradiation for carcinoma of the uterine cervix using split course technique. Gynecol Oncol (1975) 0.81
Single agent vs combination chemotherapy in the treatment of ovarian cancer. Obstet Gynecol (1977) 0.81
An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors. Am J Obstet Gynecol (1973) 0.80
Survival after ovarian cancer induced intestinal obstruction. Gynecol Oncol (1982) 0.80
The labelling in vivo of nuclear and cytoplasmic RNA of pigeon reticulocytes. Biochim Biophys Acta (1968) 0.80
Paget's disease of the vulva: a clinicopathologic study of eight cases. Obstet Gynecol (1975) 0.80
Reconstructive surgery for infertility at the Boston Hospital for Women. Am J Obstet Gynecol (1970) 0.79
Lymphocyte response to autologous tumor antigen(s) and phytohemagglutinin in ovarian cancer patients. Cancer (1975) 0.79
Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3. Cancer Res (1985) 0.79
Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract. Gynecol Oncol (1982) 0.79
Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection. Am J Obstet Gynecol (1985) 0.79
Androgen and gonadotropin dynamics in testicular feminization syndrome. J Clin Endocrinol Metab (1972) 0.79
Primary treatment of advanced ovarian adenocarcinoma, stages III and IV. Natl Cancer Inst Monogr (1975) 0.78
Tumor marker in ovarian cancer. Tumor-associated antigen. N Y State J Med (1977) 0.78
Action of endo-alpha-N-acetyl-D-galactosaminidase on synthetic glycosides including chromogenic substrates. Anal Biochem (1978) 0.78
Synthesis of p-nitrophenyl 2-acetamido-2-deoxy-O-beta-D-galactopyranosyl-beta-D-glucopyranosides. Carbohydr Res (1975) 0.78
Murine monoclonal antibodies against galactosyltransferase from the ascites of ovarian cancer patients. Cancer Res (1984) 0.78
Preoperative and intraoperative evaluation in ovarian malignancy. Obstet Gynecol (1976) 0.78
Tumour-associated antigens for cystadenocarcinoma of the ovary. Clin Obstet Gynaecol (1983) 0.78
Tumor-associated antigen for cystadenocarcinomas of the ovary. Natl Cancer Inst Monogr (1975) 0.78
Substrate specificity and other properties of the beta-D-galactosidase from Aspergillus niger. Carbohydr Res (1983) 0.78
Rapid procedures for determination of endo-N-acetyl-alpha-D-galactosaminidase in Clostridium perfringens, and of the substrate specificity of exo-beta-D-galactosidases. Carbohydr Res (1980) 0.77
Para-aortic node irradiation in carcinomas. Cancer (1974) 0.77
Para-aortic lymphadenectomy in staging patients with advanced local cervical cancer. Obstet Gynecol (1974) 0.77
Para-aortic lymph node metastasis in FIGO stage I endometrial carcinoma. Value of surgical staging and results of treatment. N Y State J Med (1982) 0.77
Melanoma of the vulva. Obstet Gynecol (1975) 0.77
Specific activity of alpha-L-fucosidase in sera with phenotypes of either low, intermediate, or high total enzyme activity and in a fucosidosis serum. Biochem Genet (1986) 0.77
Identification of a human cancer-associated antigen defined with monoclonal antibody. Cancer Res (1984) 0.77
Purification of a beta-D-galactosidase from bovine liver by affinity chromatography. Carbohydr Res (1984) 0.76
Correlation of UDP-galactose glycoprotein:galactosyltransferase levels in the sera with the clinical status of ovarian cancer patients. Cancer Lett (1978) 0.76
cis-Dichlorodiammineplatinum(II) as third-line chemotherapy in advanced ovarian adenocarcinoma. Cancer Treat Rep (1978) 0.76
Use of N-acetyl-2'-O-methyllactosamine as a specific acceptor for the determination of alpha-L-(1----3)-fucosyltransferase in human serum. Anal Biochem (1986) 0.76
Hydroxyurea and radiation therapy in advanced cervical cancer. Am J Obstet Gynecol (1974) 0.76
Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma. Cancer Treat Rep (1984) 0.76
The distribution of acetylcholinesterase and catecholamines in the vertical lobe of Octopus vulgaris. Brain Res (1971) 0.76
Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients. J Natl Cancer Inst (1981) 0.76
Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report. Obstet Gynecol (1980) 0.76
Para-aortic lymphadenectomy, aortic node biopsy, and aortic lymphangiography in staging patients with advanced cervical cancer. Cancer (1973) 0.76
delta-aminolaevulinic acid dehydratase activity and focal brain haemorrhages in lead-treated rats. Acta Neuropathol (1977) 0.75
Clear-cell adenocarcinoma ("mesonephroma") of the vagina. 3 cases associated with maternal synthetic nonsteroid estrogen therapy. Cancer (1972) 0.75
Modified procedure for detection of GDP-L-fucose:galactoside 2'-fucosyltransferase. Clin Chim Acta (1980) 0.75
Familial ovarian cancer: increasing in frequency? Obstet Gynecol (1982) 0.75
Combined radical surgery, radiation therapy and chemotherapy in infants with vulvovaginal embryonal rhabdomyosarcoma. Obstet Gynecol (1973) 0.75
Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy, and radiation therapy. Am J Obstet Gynecol (1975) 0.75
High-dose methotrexate with cyclophosphamide and cis-platinum in treatment of advanced ovarian carcinoma. Gynecol Oncol (1979) 0.75
Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma. Cancer Treat Rep (1981) 0.75
Formation of catecholamines and acid metabolites by Octopus brain. Experientia (1973) 0.75
Adriamycin in localized and metastatic uterine sarcomas. J Surg Oncol (1979) 0.75
Determination of serum galactosyltransferase levels in ovarian cancer patients for the evaluation of the effectiveness of therapeutic programs. Cancer Lett (1980) 0.75
Beta-hexosaminidase activities and isoenzymes in normal human ovary and ovarian adenocarcinoma. Cancer (1982) 0.75
Synthesis of benzyl 2-acetamido-3-O- and -6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-alpha -D-galactopyranoside. Carbohydr Res (1983) 0.75
The value of tumor markers in cancer of the ovary. Int J Radiat Oncol Biol Phys (1981) 0.75
Doxorubicin, cyclophosphamide, and 5-fluorouracil in patients with carcinoma of the cervix or vagina. Cancer Treat Rep (1981) 0.75
Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 percent 5-fluorouracil cream. Am J Obstet Gynecol (1979) 0.75
Comparison of cytosol estrogen receptor status in ovarian carcinoma using different radiolabeled ligands and methods. J Surg Oncol (1982) 0.75
Stage III uterine sarcoma: case report and literature review. Gynecol Oncol (1979) 0.75
Synthesis of 6-O-alpha-L-fucopyranosyl-D-galactose. Carbohydr Res (1974) 0.75
Synthesis of 2-acetamido-2-deoxy-1-thio-beta-D-glucopyranosides. Carbohydr Res (1973) 0.75
Intraperitoneal chromic phosphate in peritoneoscopically confirmed stage I ovarian adenocarcinoma. Am J Obstet Gynecol (1982) 0.75
Phenyl 2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-alpha-D-galactopyranoside, a substrate for sialyltransferase. Carbohydr Res (1981) 0.75
Synthesis of 2-acetamido-2-deoxy-3-O-alpha-L-fucopyranosyl-D-glucose. Carbohydr Res (1974) 0.75
Chemotherapy in management of mixed mesodermal tumors of the ovary. Gynecol Oncol (1980) 0.75
Delayed hypersensitivity reactions vs chemotherapy and immunotherapy responses in women with ovarian adenocarcinoma. J Surg Oncol (1981) 0.75
Evaluation of 5'-nucleotidase as an enzyme marker in ovarian carcinoma. Cancer (1981) 0.75
A simple, specific radiometric assay for 5'-nucleotidase. Anal Biochem (1979) 0.75
The chemical synthesis of O-alpha-L-fucopyranosyl-(1 goes to 2)-O-beta-D-galactopyranosyl-(1 goes to 3)-O-[alpha-L-fucopyranosyl-(1 goes to 4)]-2-acetamido-2-deoxy-D-glucopyranose, the Lewis b blood-group antigenic determinant. Carbohydr Res (1981) 0.75
Synthesis and use of p-nitrophenyl-2-O-(alpha-L-fucopyranosyl)-beta-D-galactopyranoside for the rapid detection of substrate-specific alpha-L-fucosidases. Anal Biochem (1981) 0.75
Inhibition of galactosyltransferase by 5-fluorouracil. Biochem Pharmacol (1982) 0.75
Second-look laparoscopy prior to proposed second-look laparotomy. Obstet Gynecol (1980) 0.75